SugarBud announces strategic relationship with Phylos Bioscience Inc. regarding the characterization and analysis of SugarBud's Genetic Library

About this update from Sucro Limited

[{"type":"text","content":"\n\n\n\nSugarBud announces strategic relationship with Phylos Bioscience Inc. regarding the characterization and analysis of SugarBud's Genetic Library\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nCALGARY, Jan. 31, 2019\n\n\n\nTSX-Venture Exchange: SUGR, SUGR.WT \n CALGARY, Jan. 31, 2019 /CNW/ - SugarBud Craft Growers Corp. (\"SugarBud\" or the \"Company\") is pleased to announce that it has entered into a strategic relationship with Phylos Bioscience Inc. (\"Phylos\") for the characterization and analysis of SugarBud's future cannabis strains (the \"Genetic Library\"). With the declaration afforded to SugarBud as a late-stage applicant under Health Canada's Cannabis Regulations, the Company has line of sight to a Genetic Library of over 400 top-tier strains, including the latest \"designer\" hybrid strains and foundational landrace strains.   \n\n \n \n\n \nCraig Kolochuk, President and Chief Executive Officer of SugarBud stated: \"Phylos has extensive knowledge of the global cannabis market and the rapidly evolving needs of medical and recreational cannabis users. Phylos will analyze chemotype, phenotype, and genotype data sourced from SugarBud's Genetic Library, which will provide insights that could include genetic profiles, potential yields, terpene levels, THC and CBD content, plant sizes, and vegetation and flowering times. This data will not only assist SugarBud in determining the optimal cannabis strains for production from an economic standpoint, it will also ensure that SugarBud's customers are provided with a diverse product offering and certainty regarding the cannabis that they are consuming.\" \nAbout Phylos Bioscience Inc. \nPhylos is the world's leading provider of cannabis genomics. Using modern molecular genetics and computational biology, Phylos is driving the development and improvement of hemp and drug varieties for optimal performance across diverse agricultural environments. The Phylos world-class team supports research and development, breeding partnerships with global partners, and cultivation businesses...

More updates from Sucro Limited